ARTICLE | Financial News

Step Pharma adds €8.6M to series A

December 1, 2017 12:04 AM UTC

Autoimmune play Step Pharma S.A.S. (Paris, France) raised €8.6 million ($10.2 million) in the second and final close of a series A round, bringing the total to €14.5 million ($17.1 million). New investor Pontifax Group joined existing investors Kurma Partners, Bpifrance (Fonds Biothérapies Innovantes et Maladies Rares), the Inserm Transfert subsidiary of Institut National de la Sante et de la Recherche Medicale (INSERM), Idinvest, Sygnature Discovery Ltd. (Nottingham, U.K.) and the Imagine Institute.

Step plans to use the funds to advance its oral immunomodulators into the clinic for autoimmune diseases, including rheumatoid arthritis, multiple sclerosis, psoriasis and graft-versus-host disease (GvHD)...

BCIQ Company Profiles

Step Pharma S.A.S.

BCIQ Target Profiles

CTP synthase 1 (CTPS1)